| Powder production and particle engineering for dry powder inhaler formulations YW Lin, J Wong, L Qu, HK Chan, QT Zhou Current pharmaceutical design 21 (27), 3902-3916, 2015 | 101 | 2015 |
| Bacteriophage uptake by mammalian cell layers represents a potential sink that may impact phage therapy MC Bichet, WH Chin, W Richards, YW Lin, L Avellaneda-Franco, ... Iscience 24 (4), 2021 | 83 | 2021 |
| Pharmacokinetics/pharmacodynamics of pulmonary delivery of colistin against Pseudomonas aeruginosa in a mouse lung infection model YW Lin, QT Zhou, SE Cheah, J Zhao, K Chen, J Wang, HK Chan, J Li Antimicrobial agents and chemotherapy 61 (3), 10.1128/aac. 02025-16, 2017 | 66 | 2017 |
| Comparative metabolomics and transcriptomics reveal multiple pathways associated with polymyxin killing in Pseudomonas aeruginosa ML Han, Y Zhu, DJ Creek, YW Lin, AD Gutu, P Hertzog, T Purcell, ... MSystems 4 (1), 10.1128/msystems. 00149-18, 2019 | 65 | 2019 |
| Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections S Yu, S Wang, P Zou, G Chai, YW Lin, T Velkov, J Li, W Pan, QT Zhou International journal of pharmaceutics 575, 118915, 2020 | 60 | 2020 |
| Aerosolized polymyxin B for treatment of respiratory tract infections: determination of pharmacokinetic-pharmacodynamic indices for aerosolized polymyxin B against Pseudomonas … YW Lin, Q Zhou, NJ Onufrak, V Wirth, K Chen, J Wang, A Forrest, ... Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00211-17, 2017 | 60 | 2017 |
| Alterations of metabolic and lipid profiles in polymyxin-resistant Pseudomonas aeruginosa ML Han, Y Zhu, DJ Creek, YW Lin, D Anderson, HH Shen, B Tsuji, ... Antimicrobial agents and chemotherapy 62 (6), 10.1128/aac. 02656-17, 2018 | 58 | 2018 |
| Engineering of nebulized metal–phenolic capsules for controlled pulmonary deposition Y Ju, C Cortez‐Jugo, J Chen, TY Wang, AJ Mitchell, E Tsantikos, ... Advanced Science 7 (6), 1902650, 2020 | 57 | 2020 |
| Potential toxicity of polymyxins in human lung epithelial cells MU Ahmed, T Velkov, YW Lin, B Yun, CJ Nowell, F Zhou, QT Zhou, ... Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 02690-16, 2017 | 54 | 2017 |
| Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance Y Zhu, J Lu, ML Han, X Jiang, MAK Azad, NA Patil, YW Lin, J Zhao, Y Hu, ... Advanced Science 7 (15), 2000704, 2020 | 50 | 2020 |
| Co-delivery of ciprofloxacin and colistin in liposomal formulations with enhanced in vitro antimicrobial activities against multidrug resistant Pseudomonas aeruginosa S Wang, S Yu, Y Lin, P Zou, G Chai, HH Yu, H Wickremasinghe, N Shetty, ... Pharmaceutical research 35, 1-13, 2018 | 50 | 2018 |
| Metabolomics study of the synergistic killing of polymyxin B in combination with amikacin against polymyxin-susceptible and-resistant Pseudomonas aeruginosa M Hussein, ML Han, Y Zhu, Q Zhou, YW Lin, REW Hancock, D Hoyer, ... Antimicrobial Agents and Chemotherapy 64 (1), 10.1128/aac. 01587-19, 2019 | 39 | 2019 |
| Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study YW Lin, RY Chang, GG Rao, B Jermain, ML Han, JX Zhao, K Chen, ... Clinical Microbiology and Infection 26 (9), 1229-1235, 2020 | 38 | 2020 |
| Lipidomic Analysis of the Outer Membrane Vesicles from Paired Polymyxin-Susceptible and -Resistant Klebsiella pneumoniae Clinical Isolates R Jasim, ML Han, Y Zhu, X Hu, MH Hussein, YW Lin, Q Zhou, CYD Dong, ... International Journal of Molecular Sciences 19 (8), 2356, 2018 | 31 | 2018 |
| Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation SC Nang, YW Lin, AP Fabijan, RYK Chang, GG Rao, J Iredell, HK Chan, ... Clinical Microbiology and Infection 29 (6), 702-709, 2023 | 27 | 2023 |
| Comparative metabolomics reveals key pathways associated with the synergistic killing of colistin and sulbactam combination against multidrug-resistant Acinetobacter baumannii ML Han, X Liu, T Velkov, YW Lin, Y Zhu, DJ Creek, CK Barlow, HH Yu, ... Frontiers in Pharmacology 10, 754, 2019 | 27 | 2019 |
| Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation S Mangal, H Park, L Zeng, HY Heidi, Y Lin, T Velkov, JA Denman, ... International journal of pharmaceutics 548 (1), 443-453, 2018 | 25 | 2018 |
| Novel polymyxin combination with the antiretroviral zidovudine exerts synergistic killing against NDM-producing multidrug-resistant Klebsiella pneumoniae YW Lin, N Abdul Rahim, J Zhao, ML Han, HH Yu, H Wickremasinghe, ... Antimicrobial Agents and Chemotherapy 63 (4), 10.1128/aac. 02176-18, 2019 | 24 | 2019 |
| Mechanistic insights from global metabolomics studies into synergistic bactericidal effect of a polymyxin B combination with tamoxifen against cystic fibrosis MDR Pseudomonas … M Hussein, ML Han, Y Zhu, EK Schneider-Futschik, X Hu, QT Zhou, ... Computational and structural biotechnology journal 16, 587-599, 2018 | 23 | 2018 |
| Pulmonary pharmacokinetics of colistin following administration of dry powder aerosols in rats YW Lin, QT Zhou, Y Hu, NJ Onufrak, S Sun, J Wang, A Forrest, HK Chan, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 00973-17, 2017 | 22 | 2017 |
Qi (Tony) ZhouDepartment of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University在 purdue.edu 的电子邮件经过验证
